Mendota Financial Group »

Halozyme Therapeutics shares owned by Mendota Financial Group

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mendota Financial Group from 13F filings

Historical chart of Mendota Financial Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Mendota Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Mendota Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $150k 2.6k 57.24
2024-06-30 $165k 3.2k 52.36
2024-03-31 $129k 3.2k 40.68
2023-12-31 $123k 3.3k 36.96
2023-09-30 $127k 3.3k 38.20

More positions owned by Mendota Financial Group

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Equity Market (DFUS)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Capital Group International SHS (CGIE)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Loews Corporation (L)
Meta Platforms Cl A (META)
PAR Technology Corporation (PAR)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)

View all positions for Mendota Financial Group

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics